健胃舒颗粒“从脾论治”反流性食管炎的疗效及对患者胃动力和食管酸环境的影响Efficacy of Jianweishu granules in treating reflux esophagitis from the perspective of "treating from the spleen" and its effects on gastric motility and esophageal acid environment
李立平,刘育伟,李紫昕,吴少华,曾淇,罗绍驹,张伦
摘要(Abstract):
目的:基于“从脾论治”理论,观察健胃舒颗粒对脾虚阳郁型反流性食管炎(reflux esophagitis, RE)患者食管动力学、胃电活动及食管酸暴露的影响,并探讨其机制。方法:纳入46例脾虚阳郁型RE患者为研究对象,随机分为两组,每组各23例。对照组予艾司奥美拉唑联合莫沙必利治疗,治疗组予健胃舒颗粒治疗,疗程均为8周。比较两组治疗前后的中医证候积分、反流性食管炎量表(reflux disease questionnaire, RDQ)评分、食管测压、24 h食管pH值监测及动态胃电图变化。结果:(1)食管动力:治疗后,治疗组的下食管括约肌残余压显著低于对照组[(5.94±1.24) mmHg vs (8.39±1.46) mmHg,P<0.001],远端收缩积分显著高于对照组[(1 516.26±594.42) mmHg·cm·s vs (1 188.83±390.77) mmHg·cm·s,P=0.033]。(2)胃电节律:治疗组节律紊乱百分比显著低于对照组[(12.18±3.15)%vs (14.63±4.50)%,P=0.038]。(3)中医证候:治疗组总积分更低[(8.48±3.31)%vs (12.04±4.97)%,P=0.006],改善烧心(P=0.030)及咽喉异物感(P=0.001)更优。(4)酸暴露:两组DeMeester评分及RDQ评分均较治疗前显著改善(P<0.001),但组间差异无统计学意义(P>0.05)。结论:健胃舒颗粒可有效治疗脾虚阳郁型RE,其机制在于立足“从脾论治”,综合改善食管动力、食管酸环境及胃电活动以达到临床疗效。
关键词(KeyWords): 反流性食管炎;健胃舒颗粒;脾虚阳郁;从脾论治;胃电活动;食管动力学
基金项目(Foundation): 国家中医药管理局科技司共建项目(No:GZY-KJS-GD-2025-016);; 岭南邱氏脾胃流派传承工作室项目(No:20261236);; 第五批全国优秀中医临床人才研修项目(No:国中医药人教函[2022]1号);; 通阳创新工作室(No:粤工总女委[2024]31号);; 广东省中医药局科研项目(No:20264043)
作者(Author): 李立平,刘育伟,李紫昕,吴少华,曾淇,罗绍驹,张伦
参考文献(References):
- [1] 中华医学会消化病学分会胃肠动力学组,胃肠功能性疾病协作组,食管疾病协作组.中国胃食管反流病诊疗规范[J].中华消化杂志,2023,43(9):588-598.
- [2] Iwakiri K,Fujiwara Y,Manabe N,et al.Evidence-based clinical practice guidelines for gastroesophageal reflux disease 2021[J].J Gastroenterol,2022,57(4):267-285.
- [3] Chen J,Dong PW,Chen SF,et al.The Los Angeles-B esophagitis is a conclusive diagnostic evidence for gastroesophageal reflux disease:the validation of Lyon Consensus 2.0[J].Gastroenterol Rep,2025,13:goaf004.
- [4] Yadlapati R,Vaezi MF,Vela MF,et al.Management options for patients with GERD and persistent symptoms on proton pump inhibitors:recommendations from an expert panel[J].Am J Gastroenterol,2018,113(7):980-986.
- [5] 中国中西医结合学会消化系统疾病专业委员会.胃食管反流病中西医结合诊疗专家共识(2025年)[J].中国中西医结合消化杂志,2025,33(3):217-229.
- [6] 张伦,刘育伟,陈懿科,等.健胃舒颗粒治疗脾虚阳郁型慢性萎缩性胃炎的临床疗效观察[J].广州中医药大学学报,2026,43(4):905-913.
- [7] 张北华,周秉舵,唐旭东.胃食管反流病中医诊疗专家共识(2023)[J].中医杂志,2023,64(18):1935-1944.
- [8] 国家药监局药审中心.国家药监局药审中心关于发布《中药新药用于慢性胃炎的临床疗效评价技术指导原则(试行)》《中药新药用于胃食管反流病的临床疗效评价技术指导原则(试行)》的通告(2022年第47号)[J].中国临床药理学杂志,2023,39(4):512.
- [9] Cao Y,Yan XY,Ma XQ,et al.Validation of a survey methodology for gastroesophageal reflux disease in China[J].BMC Gastroenterol,2008,8:37.
- [10] 张玲,姚玮艳,邹多武.胃食管反流病临床诊断中检查方法应用策略[J].诊断学理论与实践,2025,24(4):359-364.
- [11] 邱健行.岭南邱氏脾胃流派[M].北京:人民卫生出版社,2025:231-231.
- [12] Yadlapati R,Kahrilas PJ,Fox MR,et al.Esophageal motility disorders on high-resolution manometry:Chicago classification version 4.0??[J].Neurogastroenterol Motil,2021,33(1):e14058.
- [13] Gorti H,Samo S,Shahnavaz N,et al.Distal esophageal spasm:Update on diagnosis and management in the era of high-resolution manometry[J].World J Clin Cases,2020,8(6):1026-1032.
- [14] Chen RR,Chen QZ,Feng BC,et al.Characteristics of reflux and gastric electrical activity in gastroesophageal reflux disease with ineffective esophageal motility[J].J Digest Diseases,2023,24(1):2-9.
- [15] Xu W,Simmonds S,Foong D,et al.Association between gastric rhythm and gastroesophageal reflux defined by simultaneous body surface gastric mapping and 24-h pH testing[J].Am J Physiol Gastrointest Liver Physiol,2026,330(1):G62-G71.